Open-Angle Glaucoma

A history of migraine, with or without aura, was a significant risk factor for open-angle glaucoma onset among a cohort of South Korean adults, according to a study published in the Journal of Glaucoma.

Patients with glaucoma treated with iDose TR experienced sustained IOP reductions, according to a press release from Glaukos.

Some megatrends in health care are occurring that deserve our attention.

January is National Glaucoma Awareness Month, according to Prevent Blindness, and the organization is providing free resources to educate the public on the importance of early detection and care.

A bio-interventional cyclodialysis procedure with allograft scleral reinforcement helped lower IOP in patients with glaucoma through uveoscleral outflow enhancement, according to a study.

Timolol microdrops administered with the Nanodropper Adaptor were as effective as conventional drops at lowering IOP among patients with open-angle glaucoma and ocular hypertension, according to a study published in Ophthalmology.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Patrick Mooney, CEO of Spyglass Pharma, discusses the company’s IOL-based bimatoprost drug delivery platform for patients with open-angle glaucoma or ocular hypertension.

Most patients with open-angle glaucoma responded favorably to repeat selective laser trabeculoplasty, regardless of initial response, and experienced a longer duration of effect, according to a study in JAMA Ophthalmology.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Noureen Khan, MD, of Northern Virginia Ophthalmology Associates discusses 36-month results from the GEMINI study.

The FDA granted de novo classification to the Fysx ocular pressure adjusting pump for patients with normal-tension glaucoma or open-angle glaucoma with IOP of 21 mm Hg or less, according to a press release from Balance Ophthalmics.